Encio, Almarie V.

HRN: 20-56-63  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2026
CEFUROXIME 1.5GM (VIAL)
06/16/2026
06/18/2026
IV
1.5g
Q12h
Imminent Delivery; Leukocytosis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines